The Effects of Semaglutide on Health-Related Quality of Life in Adults with Type 2 Diabetes and Chronic Kidney Disease: FLOW trial
Johannes Mann1,2; Ida Kirstine Bull Rasmussen3; Thomas P Gunnarsson3; Prachi Priyadarshini4;Søren Rasmussen3; Peter Rossing5
MATERIALS AVAILABLE
Slide
Friday, 05 June 2026
15:33 - 15:39
BST
SHORT ORAL PRESENTATION
Mechanistic kidney effects of semaglutide by MRI outcomes: a post-hoc analysis of the REMODEL trial
Paul D. Hockings1; Patter Bjornstad2,3; David Z.I. Cherney4; Milenta M. Chacko 5;Thomas P. Gunnarsson6; Isabelle Kazes7; Emma T.B. Olesen6; Tina Thethi 8; Menno Pruijm9